{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:59Z","timestamp":1707524339079},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,29]]},"DOI":"10.7759\/cureus.16033","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T19:12:30Z","timestamp":1624993950000},"source":"Crossref","is-referenced-by-count":0,"title":["Substance Use Disorders in Patients With Parkinson\u2019s Disease and Adverse Hospitalization Outcomes: A National Inpatient Study"],"prefix":"10.7759","author":[{"given":"Jaskaranpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramneek K","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija T","family":"Kubra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna S","family":"Canenguez Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry K","family":"Onyeaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabiha","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge C","family":"Amuk Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras C","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, et al.. Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis. 2018, 4:21. 10.1038\/s41531-018-0058-0","journal-title":"NPJ Parkinsons Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12568","article-title":"Epidemiology of Parkinson's disease-east versus west","volume":"5","author":"Abbas MM","year":"2018","unstructured":"Abbas MM, Xu Z, Tan LCS. Epidemiology of Parkinson's disease-east versus west. Mov Disord Clin Pract. 2018, 5:14-28. 10.1002\/mdc3.12568","journal-title":"Mov Disord Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2015.03.013","article-title":"Drugs of abuse and Parkinson's disease","volume":"64","author":"Mursaleen LR","year":"2016","unstructured":"Mursaleen LR, Stamford JA. Drugs of abuse and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2016, 64:209-17. 10.1016\/j.pnpbp.2015.03.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref4","article-title":"Parkinson\u2019s disease and drug abuse","volume":"7","author":"Tripathi K","year":"2017","unstructured":"Tripathi K, Tripathi R. Parkinson\u2019s disease and drug abuse. EC Neurology. 2017, 7:117-27.","journal-title":"EC Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/138161211795164103","article-title":"Connecting Parkinson's disease and drug addiction: common players reveal unexpected disease connections and novel therapeutic approaches","volume":"17","author":"Gramage E","year":"2011","unstructured":"Gramage E, Herrad\u00f3n G. Connecting Parkinson's disease and drug addiction: common players reveal unexpected disease connections and novel therapeutic approaches. Curr Pharm Des. 2011, 17:449-61. 10.2174\/138161211795164103","journal-title":"Curr Pharm Des"},{"key":"ref6","unstructured":"Overview of the national (nationwide) inpatient sample. (2021). Accessed. May 15, 2021: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref7","unstructured":"NIS description of data elements. (2021). Accessed. May 15, 2021: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/nisdde.jsp."},{"key":"ref8","unstructured":"Sex and gender differences in substance use. (2018). Accessed. May 16, 2021: https:\/\/www.drugabuse.gov\/publications\/research-reports\/substance-use-in-women\/sex-gender-differences-in-substance-use."},{"key":"ref9","unstructured":"Men more likely than women to face substance use disorders and mental illness. (2019). Accessed. May 5, 2021: https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/articles\/2019\/06\/03\/men-more-likely-than-women-to-face-substance-u...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-150533","article-title":"Alcohol consumption and Parkinson's disease risk: a review of recent findings","volume":"5","author":"Bettiol SS","year":"2015","unstructured":"Bettiol SS, Rose TC, Hughes CJ, Smith LA. Alcohol consumption and Parkinson's disease risk: a review of recent findings. J Parkinsons Dis. 2015, 5:425-42. 10.3233\/JPD-150533","journal-title":"J Parkinsons Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan RC","year":"2012","unstructured":"Callaghan RC, Cunningham JK, Sykes J, Kish SJ. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 2012, 120:35-40. 10.1016\/j.drugalcdep.2011.06.013","journal-title":"Drug Alcohol Depend"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.09.025","article-title":"The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort","volume":"20","author":"Szewczyk-Krolikowski K","year":"2014","unstructured":"Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Wade-Martins R, Talbot K, Ben-Shlomo Y, Hu MT. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014, 20:99-105. 10.1016\/j.parkreldis.2013.09.025","journal-title":"Parkinsonism Relat Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.12.016","article-title":"Sex differences in Parkinson's disease","volume":"21","author":"Lubomski M","year":"2014","unstructured":"Lubomski M, Louise Rushworth R, Lee W, Bertram KL, Williams DR. Sex differences in Parkinson's disease. J Clin Neurosci. 2014, 21:1503-6. 10.1016\/j.jocn.2013.12.016","journal-title":"J Clin Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.02.007","article-title":"Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease","volume":"50","author":"Cholerton B","year":"2018","unstructured":"Cholerton B, Johnson CO, Fish B, et al.. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism Relat Disord. 2018, 50:29-36. 10.1016\/j.parkreldis.2018.02.007","journal-title":"Parkinsonism Relat Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve A","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D. Ageing and Parkinson's disease: why is advancing age the biggest risk factor?. Ageing Res Rev. 2014, 14:19-30. 10.1016\/j.arr.2014.01.004","journal-title":"Ageing Res Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3171\/2013.8.FOCUS13295","article-title":"Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson's disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010","volume":"35","author":"Sharma M","year":"2013","unstructured":"Sharma M, Ambekar S, Guthikonda B, Wilden J, Nanda A. Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson's disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010. Neurosurg Focus. 2013, 35:E2. 10.3171\/2013.8.FOCUS13295","journal-title":"Neurosurg Focus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.326","article-title":"Racial and socioeconomic disparities in parkinsonism","volume":"68","author":"Hemming JP","year":"2011","unstructured":"Hemming JP, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Racial and socioeconomic disparities in parkinsonism. Arch Neurol. 2011, 68:498-503. 10.1001\/archneurol.2010.326","journal-title":"Arch Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22557","article-title":"Racial differences in the diagnosis of Parkinson's disease","volume":"24","author":"Dahodwala N","year":"2009","unstructured":"Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Mov Disord. 2009, 24:1200-5. 10.1002\/mds.22557","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s1353-8020(02)00024-x","article-title":"Alkaloids, alcohol and parkinson's disease","volume":"8","author":"Collins MA","year":"2002","unstructured":"Collins MA. Alkaloids, alcohol and parkinson's disease. Parkinsonism Relat Disord. 2002, 8:417-22. 10.1016\/s1353-8020(02)00024-x","journal-title":"Parkinsonism Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.42","article-title":"Clinical and pathological features of alcohol-related brain damage","volume":"7","author":"Zahr NM","year":"2011","unstructured":"Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol. 2011, 7:284-94. 10.1038\/nrneurol.2011.42","journal-title":"Nat Rev Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440307","article-title":"Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography","volume":"44","author":"Gilman S","year":"1998","unstructured":"Gilman S, Koeppe RA, Adams KM, et al.. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography. Ann Neurol. 1998, 44:326-33. 10.1002\/ana.410440307","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4813","article-title":"Pros and cons of marijuana in treatment of Parkinson's disease","volume":"11","author":"Patel RS","year":"2019","unstructured":"Patel RS, Kamil S, Shah MR, Bhimanadham NN, Imran S. Pros and cons of marijuana in treatment of Parkinson's disease. Cureus. 2019, 11:e4813. 10.7759\/cureus.4813","journal-title":"Cureus"},{"key":"ref23","article-title":"Preventing levodopa-induced dyskinesias","volume":"47","author":"Olanow CW","year":"2000","unstructured":"Olanow CW, Obeso JA. Preventing levodopa-induced dyskinesias. Ann Neurol. 2000, 47:S167-76.","journal-title":"Ann Neurol"},{"key":"ref24","article-title":"Molecular basis of levodopa-induced dyskinesias","volume":"47","author":"Calon F","year":"2000","unstructured":"Calon F, Grondin R, Morissette M, Goulet M, Blanchet PJ, Di Paolo T, B\u00e9dard PJ. Molecular basis of levodopa-induced dyskinesias. Ann Neurol. 2000, 47:S70-8.","journal-title":"Ann Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13045","article-title":"The delta-opioid receptor and Parkinson's disease","volume":"24","author":"Huang JZ","year":"2018","unstructured":"Huang JZ, Ren Y, Xu Y, et al.. The delta-opioid receptor and Parkinson's disease. CNS Neurosci Ther. 2018, 24:1089-99. 10.1111\/cns.13045","journal-title":"CNS Neurosci Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420508","article-title":"Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias","volume":"42","author":"Piccini P","year":"1997","unstructured":"Piccini P, Weeks RA, Brooks DJ. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Ann Neurol. 1997, 42:720-6. 10.1002\/ana.410420508","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27579","article-title":"The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States","volume":"34","author":"Martinez-Martin P","year":"2019","unstructured":"Martinez-Martin P, Macaulay D, Jalundhwala YJ, Mu F, Ohashi E, Marshall T, Sail K. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States. Mov Disord. 2019, 34:236-45. 10.1002\/mds.27579","journal-title":"Mov Disord"},{"key":"ref28","article-title":"The economic and quality of life burden associated with Parkinson's disease: a focus on symptoms","volume":"18","author":"Boland DF","year":"2012","unstructured":"Boland DF, Stacy M. The economic and quality of life burden associated with Parkinson's disease: a focus on symptoms. Am J Manag Care. 2012, 18:S168-75.","journal-title":"Am J Manag Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0493-1","article-title":"Interdisciplinary teamwork for the treatment of people with Parkinson's disease and their families","volume":"14","author":"Giladi N","year":"2014","unstructured":"Giladi N, Manor Y, Hilel A, Gurevich T. Interdisciplinary teamwork for the treatment of people with Parkinson's disease and their families. Curr Neurol Neurosci Rep. 2014, 14:493. 10.1007\/s11910-014-0493-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s1353-8020(09)70819-3","article-title":"Multidisciplinary care for patients with parkinson's disease","volume":"15","author":"van der Marck MA","year":"2009","unstructured":"van der Marck MA, Kalf JG, Sturkenboom IH, Nijkrake MJ, Munneke M, Bloem BR. Multidisciplinary care for patients with parkinson's disease. Parkinsonism Relat Disord. 2009, 15:219-23. 10.1016\/s1353-8020(09)70819-3","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/62567-substance-use-disorders-in-patients-with-parkinsons-disease-and-adverse-hospitalization-outcomes-a-national-inpatient-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:53Z","timestamp":1707507113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/62567-substance-use-disorders-in-patients-with-parkinsons-disease-and-adverse-hospitalization-outcomes-a-national-inpatient-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.16033","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}